Cargando…

TNF-α and NF-κB signaling play a critical role in cigarette smoke-induced epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy

Proliferative vitreoretinopathy (PVR) is characterized by the growth and contraction of cellular membranes within the vitreous cavity and on both surfaces of the retina, resulting in recurrent retinal detachments and poor visual outcomes. Proinflammatory cytokines like tumor necrosis factor alpha (T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Victor, Heffer, Alison, Roztocil, Elisa, Feldon, Steven E., Libby, Richard T., Woeller, Collynn F., Kuriyan, Ajay E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436090/ https://www.ncbi.nlm.nih.gov/pubmed/36048826 http://dx.doi.org/10.1371/journal.pone.0271950

Ejemplares similares

Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model
por: Heffer, Alison M., et al.
Publicado: (2020)

A Mouse Model of Proliferative Vitreoretinopathy Induced by Intravitreal Injection of Gas and RPE Cells
por: Heffer, Alison, et al.
Publicado: (2020)

The polyether ionophore salinomycin targets multiple cellular pathways to block proliferative vitreoretinopathy pathology
por: Heffer, Alison M., et al.
Publicado: (2019)

TSHR Signaling Stimulates Proliferation Through PI3K/Akt and Induction of miR-146a and miR-155 in Thyroid Eye Disease Orbital Fibroblasts
por: Woeller, Collynn F., et al.
Publicado: (2019)

Polarity and epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy
por: Zou, Hui, et al.
Publicado: (2020)

More than Meets the Eye: The Aryl Hydrocarbon Receptor is an Environmental Sensor, Physiological Regulator and a Therapeutic Target in Ocular Disease
por: Hammond, Christine L., et al.
Publicado: (2022)

Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor
por: Hammond, Christine L., et al.
Publicado: (2019)

The aryl hydrocarbon receptor pathway controls matrix metalloproteinase-1 and collagen levels in human orbital fibroblasts
por: Roztocil, Elisa, et al.
Publicado: (2020)

MicroRNA-130a Is Elevated in Thyroid Eye Disease and Increases Lipid Accumulation in Fibroblasts Through the Suppression of AMPK
por: Hammond, Christine L., et al.
Publicado: (2021)

Exosomes mediate an epithelial‐mesenchymal transition cascade in retinal pigment epithelial cells: Implications for proliferative vitreoretinopathy
por: Zhang, Yao, et al.
Publicado: (2020)

Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy
por: Ishikawa, Keijiro, et al.
Publicado: (2015)

RPE epithelial-mesenchymal transition plays a critical role in the pathogenesis of proliferative vitreoretinopathy
por: Li, Xiaohua, et al.
Publicado: (2020)

DAPL1 prevents epithelial–mesenchymal transition in the retinal pigment epithelium and experimental proliferative vitreoretinopathy
por: Ma, Xiaoyin, et al.
Publicado: (2023)

Yes‐associated protein is essential for proliferative vitreoretinopathy development via the epithelial‐mesenchymal transition in retinal pigment epithelial fibrosis
por: Zhang, Wei, et al.
Publicado: (2021)

Long noncoding RNA ERLR mediates epithelial-mesenchymal transition of retinal pigment epithelial cells and promotes experimental proliferative vitreoretinopathy
por: Yang, Shuai, et al.
Publicado: (2021)

Myo/Nog Cells Give Rise to Myofibroblasts During Epiretinal Membrane Formation in a Mouse Model of Proliferative Vitreoretinopathy
por: Crispin, Mara, et al.
Publicado: (2023)

Experimental Models to Study Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy
por: Datlibagi, Azine, et al.
Publicado: (2023)

METTL3 attenuates proliferative vitreoretinopathy and epithelial‐mesenchymal transition of retinal pigment epithelial cells via wnt/β‐catenin pathway
por: Ma, Xinqi, et al.
Publicado: (2021)

Endogenous or Exogenous Retinal Pigment Epithelial Cells: A Comparison of Two Experimental Animal Models of Proliferative Vitreoretinopathy
por: Wong, Chee Wai, et al.
Publicado: (2020)

Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes
por: Telander, David G., et al.
Publicado: (2016)

Substance P prevents development of proliferative vitreoretinopathy in mice by modulating TNF-α
por: Yoo, Kyungsang, et al.
Publicado: (2017)

Proliferative Vitreoretinopathy and Genetic Profile
por: Ghasemi Falavarjani, Khalil
Publicado: (2013)

Proliferative Vitreoretinopathy: A Reappraisal
por: Carpineto, Paolo, et al.
Publicado: (2023)

Trichostatin A Inhibits Retinal Pigmented Epithelium Activation in an In Vitro Model of Proliferative Vitreoretinopathy
por: Por, Elaine D., et al.
Publicado: (2016)

A therapeutic perspective for proliferative vitreoretinopathy based on the inhibition of epithelial-mesenchymal transition by miR-194
por: Bencivenga, Maria, et al.
Publicado: (2020)

Proliferative vitreoretinopathy: current and emerging treatments
por: Sadaka, Ama, et al.
Publicado: (2012)

The impact of octreotide in experimental proliferative vitreoretinopathy
por: Evren, Ozge, et al.
Publicado: (2013)

Fulminant proliferative vitreoretinopathy in syphilitic uveitis
por: Queiroz, Rafael de Pinho, et al.
Publicado: (2016)

Intravitreal methotrexate infusion for proliferative vitreoretinopathy
por: Sadaka, Ama, et al.
Publicado: (2016)

Intravitreal methotrexate for the treatment of proliferative vitreoretinopathy
por: Benner, Jeffrey David, et al.
Publicado: (2019)

MeCP2‐421‐mediated RPE epithelial‐mesenchymal transition and its relevance to the pathogenesis of proliferative vitreoretinopathy
por: Li, Xiaohua, et al.
Publicado: (2020)

Overexpression p21WAF1/CIP1 in suppressing retinal pigment epithelial cells and progression of proliferative vitreoretinopathy via inhibition CDK2 and cyclin E
por: Wang, Ying, et al.
Publicado: (2014)

Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy
por: Zhou, Guohong, et al.
Publicado: (2017)

Repression of Smad4 by MicroRNA-1285 moderates TGF-β-induced epithelial–mesenchymal transition in proliferative vitreoretinopathy
por: Pao, Shu-I, et al.
Publicado: (2021)

Non-viral gene therapy using RNA interference with PDGFR-α mediated epithelial-mesenchymal transformation for proliferative vitreoretinopathy
por: Wang, Jiahao, et al.
Publicado: (2023)

Subretinal Perfluorocarbon Liquid for Dissection of Proliferative Vitreoretinopathy
por: Dalma-Weiszhausz, Jose, et al.
Publicado: (2012)

Evaluation of retinectomy in the treatment of severe proliferative vitreoretinopathy
por: Mendes, Thaís Sousa, et al.
Publicado: (2015)

Retinal shortening: Ultrasonic evaluation of proliferative vitreoretinopathy
por: Takkar, Brijesh, et al.
Publicado: (2017)

Biological Involvement of MicroRNAs in Proliferative Vitreoretinopathy
por: Kaneko, Hiroki, et al.
Publicado: (2017)

Inflammatory and Fibrogenic Factors in Proliferative Vitreoretinopathy Development
por: Chaudhary, Rishika, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v0lr6un3p00e2ehq4t2tb59ndj